VivaVision Biotech Inc. to Participate at ACCESS CHINA Biotech Forum

By Yafo Life Sciences

December 26th, 2021 (Shanghai) — We are glad to announce that Wang Shen, the Founder and CEO of VivaVision Biotech Inc., has been invited to showcase at ACCESS CHINA Biotech Forum during Jan 4th – Jan13th. ACCESS CHINA Biotech Forum is the largest online corporate access event between China and the western biopharma industry.

If you are interested in listening to the live event, please register at https://biotochina.org/register/

About VivaVision Biotech Inc.

Established in August 2016, VivaVision biotech is an innovative pharmaceutical company, focusing on the research and development of innovative drugs for the treatment of ophthalmic diseases. Vivavision is committed to providing new or better treatments for millions of patients with ophthalmic diseases. The company has assembled an internationally well known ophthalmic leadership team, and has established a leading ophthalmic clinical pipeline.

About the speaker

WANG SHEN,Ph,D., Medicinal Chemist

Led projects at Abbott, Sunesis,Amgen,kainionUSA，has more than 25 years of experience in small molecule drug development

Led the discovery of Lifitgrast (FDA 2016)
Led the discovery of Venetoclax (FDA 2016)

Inventor/author of >100 patents and peer reviewd publications.

About ACCESS CHINA

ACCESS CHINA is the most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand in the Chinese market. ACCESS CHINA creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations. View more information at https://biotochina.org/access-china-forum/

More information